Adaptive radiotherapy for nasopharyngeal carcinomas: Where are we?]

[Adaptive radiotherapy for nasopharyngeal carcinomas: Where are we?]:

Related Articles

[Adaptive radiotherapy for nasopharyngeal carcinomas: Where are we?]

Bull Cancer. 2020 Mar 31;:

Authors: Hend D, Mnejja W, Fourati N, Kallel M, Siala W, Sahnoun T, Farhat L, Daoud J

Abstract

Modern high-precision radiotherapy techniques have recently incorporated the notion of anatomical variations of the patient during treatment and have tried to adapt the treatment planning to them. Adaptive radiotherapy for nasopharyngeal tumors is starting to prove its benefit nowadays. His interest is constantly being evaluated. The variations encountered during the treatment are both geometric and dosimetric. They are represented by a reduction in the macroscopic tumors volume, a change in its position and a consequent dosimetric impact. The changes also concern organs at risk with a reduction of glandular structure volumes, and a different position which increases their doses. Delivered doses to noble structures (brainstem and spinal cord) may also increase. However, difficulties are encountered in its realization. There is a problem to perfectly reproduce the patient position during the second acquisition, which impacts the fusion quality between the two CT scans. This generates an imprecision in the definition of the same treatment isocentre on the second scanner. Also, there is a difficulty in accumulated doses calculation. The indication of adaptive radiotherapy remains a subject of controversy. It should be proposed for a subgroup of patients who could benefit from this new strategy. We present here an update on the state of the art of adaptive radiotherapy for nasopharyngeal cancer.

PMID: 32245602 [PubMed - as supplied by publisher]